GSK, EvoGenix begin second project on antibodies

08/16/2007 | Age (Melbourne, Australia), The

Australian biotech EvoGenix Ltd. said it has begun the second of three proposed projects with U.K.-based GlaxoSmithKline involving technologies used to develop antibodies for the market. The latest collaboration will attempt to "improve the properties of either an antibody or a protein to ... increase the effectiveness of drugs," EvoGenix CEO Dr. Merilyn Sleigh said.

View Full Article in:

Age (Melbourne, Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN